ZoomRx vs Market Scope+

ZoomRx is a survey platform that facilitates communication between doctors, patients, and pharmaceutical companies. The application enables patient/research organizations, pharmaceutical/biotech companies, and other survey sponsoring entities to collect information from "connected real-time panels" of patients, doctors, insurance providers, pharmacists and other stakeholders in the healthcare system. The surveys taken on ZoomRx will enhance the experience and lives of all parties involved in the health-care system by quickening the rate of information flow. The surveys on ZoomRx are designed as per guidelines issued by the Council of American Survey Research Organizations (CASRO). We adhere to the code of standards and ethics laid out by CASRO. If you have any questions on ZoomRx, please e-mail: info@zoomrx.com

Market Scope, a trusted leader in ophthalmic and optometric market research over 20 years, introduces our latest data platform, Market Scope+, a robust dual-function app designed to connect eye care providers from over 2,000 practices in 60-plus countries with more than 500 ophthalmic companies through comprehensive primary and secondary market research products and services. Medical professionals can help shape the next generation of devices, pharmaceuticals, and equipment by sharing their opinions and experiences. Participate in syndicated and sponsored surveys and review practice benchmark reports. No costs are associated with the app or survey/benchmark report access. Honorariums and/or summary data reports are available on most surveys. Industry professionals can license a comprehensive range of market reports and data subscriptions, covering all regions and subspecialties. All parties can read the latest ophthalmic news and participate in weekly polls on hot topics. Our business is built on the privacy and trust of medical professionals who participate in research projects and our industry clients who license market reports and engage our experts for consultation on M&A, product launch, and market share. We are compliant with both GDPR and CIS Critical Security Controls.